2021 Conference on Retroviruses and Opportunistic Infections*

Download All
March 6-10, 2021; Virtual
Learn about the latest HIV data with live Webinars, rapid Capsule Summaries, and downloadable slides, and get global perspectives from expert commentaries on key studies from the virtual 2021 CROI.
José R. Arribas, MD
Pedro Cahn, MD, PhD
Nelly Mugo, MBChB, MMed, MPH
person default
Don Smith, MD
person default
Darrell H. S. Tan, MD, FRCPC, PhD
Dr. Zhao Yan

Global Perspectives

Data presented at CROI 2021 show that the COVID-19 pandemic has disrupted health systems around the world, affecting diagnosis and treatment of HIV and other diseases, especially in low- and middle-income countries.

Dr. Zhao Yan Released: April 19, 2021

My take on data from several Kenyan studies presented at CROI 2021, including analyses of STI incidence among girls and young women and investigations into factors associated with and strategies for promoting improved PrEP uptake.

Nelly Mugo, MBChB, MMed, MPH Released: April 15, 2021

CROI 2021 provided more data on ARV-associated weight gain and longer-term data on injectable ART. Here are my key takeaways for healthcare professionals.

person default Don Smith, MD Released: April 20, 2021

Data on long-acting ART continued to dominate the presentations at CROI 2021. Here are my thoughts on the practicalities of potentially integrating these new drugs into my practice in Canada.

person default Darrell H. S. Tan, MD, FRCPC, PhD Released: April 1, 2021

My picks for interesting HIV treatment data presented at CROI 2021 include 2 studies performed in Spain, one comparing the efficacy of fixed-dose boosted PI combination ART vs second-generation integrase inhibitors and one investigating treatment options for newly diagnosed patients with advanced HIV.

José R. Arribas, MD Released: April 1, 2021

My pick for data presented at CROI 2021 is a study comparing post-ART weight gain in people with HIV in Latin America vs Latinx people with HIV in the United States and Canada.

Pedro Cahn, MD, PhD Released: April 5, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue